After previous coronavirus disease outbreaks, such as those caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), animal models and other experimental systems demonstrated that coronavirus-specific antibodies are generated soon after infection [20,21], and can block viral entry by interfering with the Spike:ACE2 interaction [22–27]. This evidence concerns the gene CHMP5 and infection.